Developer docs
API playgroundTry for free, no card

Search company profiles

Divergence

Full company profile

uuid000k5ds

Namestring
Divergence
Legal namestring
Bayer AG
Websiteurl
divergence.com
Company typeenum
Public
Founded yearint
1863
Descriptiontext

Divergence is a privately held research and development company headquartered in St. Louis, Missouri, founded in 1999. According to its firmographic profile, the company is dedicated to the discovery of strategies for the control of parasites and other pests, placing it in the agricultural biotechnology and animal/plant health R&D sector. Its stated product focus is on developing novel parasite and pest control approaches, which historically has spanned agricultural, veterinary, and potentially human health applications.

Between 2001 and 2009, Divergence raised approximately $20.6 million in aggregate across at least six discrete funding events, including venture rounds (with participation from Ag Fund, Cultivian Ventures, Prolog Ventures, and Sandbox Industries) and non-dilutive grant funding from the National Science Foundation. The company's leadership consists of co-founder Angharad Thomas and Vice President of Discovery Research Deryck Jeremy Williams, Ph.D., indicating a research-led operating model centered on scientific discovery rather than commercial sales scale at the time of last disclosed activity.

Material data caveat: The firmographics record lists "10000+" employees, which is fundamentally inconsistent with the disclosed funding scale (~$20M total raised over an eight-year window) and with the operating profile implied by a small St. Louis R&D operation. This figure likely reflects a data-merge artifact and should be treated with caution. No revenue, pricing, customer logos, or post-2009 operating updates are disclosed in the input, so commercial traction cannot be verified.

Short descriptiontext

Divergence is a St. Louis-based, privately held R&D company founded in 1999 that develops strategies for controlling parasites and other pests, operating in the agricultural biotechnology space.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pest control research, parasite control strategies, agricultural biotechnology, crop protection R&D, nematicide discovery
Industry1 code
PRIMARYAFABAEAH
Beneficial Insects (Predators & Parasitoids)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
Product category
Agricultural Biotechnology
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Pharmaceuticals
TypeOthers
Description

Prescription pharmaceuticals across cardiology, oncology, hematology, ophthalmology, chronic kidney disease, and hormonal/reproductive health. Includes both in-market products and pipeline candidates in clinical development.

bayer.com
2Crop Science/Agriculture
TypeOthers
Description

Agricultural products including crop protection (herbicides, fungicides, insecticides), seeds and traits (including GMO biotechnology and genome editing), agriculture biologicals, and digital farming solutions for farmers worldwide.

bayer.com
3Consumer Health/Personal Health
TypeOthers
Description

Over-the-counter (OTC) consumer health products including analgesics, allergy relief, digestive health, cough and cold, skin health, hair health, vitamins, and nutritional supplements sold through retail channels.

bayer.com
4Radiology/Diagnostic Imaging
TypeHardware Sales
Description

Medical imaging equipment and contrast agents for computed tomography (CT), magnetic resonance tomography (MRI), angiography, and PET imaging systems sold to healthcare facilities.

bayer.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Operations
Pricing details1 tier
1Pharmaceutical prescription medications - pricing varies by market and indication
ModelOtherBilling cadenceMulti-year contract
Notes

Prescription pharmaceutical pricing regulated by health authorities in different countries. Pricing varies by therapeutic area, market, and reimbursement status.

bayer.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Bayer Crop Science
Description

Agricultural division offering crop protection products, seeds, digital farming solutions, and biotechnology.

bayer.com
+4 more records
Core offering1 text field

Divergence is a research and development company focused on discovering new strategies and technologies for the control of parasites and other pests in agricultural settings. The company's work centers on agricultural biotechnology, developing novel approaches to parasitic nematode and crop pest management through targeted R&D programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Commitment to reducing agriculture's environmental impact through regenerative agriculture and carbon reduction programs
+1 more record
Product overview1 text field

Bayer is a global enterprise with core competencies in health care and agriculture. The company operates as a multi-divisional organization with three main pillars: Pharmaceuticals (innovative solutions for preventing, alleviating and treating diseases including cardiology, oncology, hematology, and eye conditions), Consumer Health (personal health products including OTC medicines, vitamins, and health supplements), and Crop Science (agricultural solutions including crop protection chemicals, seeds and traits, digital farming, and biologicals). The Pharmaceuticals division leverages advanced technology platforms including AI, chemoproteomics, PROTACs, RNA-targeting small molecules, and cell and gene therapy. The Agriculture division encompasses regenerative agriculture solutions, digital farming technologies, and biotechnology programs including GMO and genome editing.

Product and service1 record
1Parasite and Pest Control R&D Services
CategoryAgricultural Biotechnology R&D
Description

Research and development services focused on discovering novel strategies and chemistries for the control of parasites (including plant-parasitic nematodes) and other agricultural pests, delivered to agricultural input companies.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-17
Description

Bayer completed acquisition of Perfuse Therapeutics, a strategic transaction to strengthen Bayer's pharmaceutical pipeline and capabilities in a specific therapeutic area (date: June 2026).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to improve access to family planning services in urban areas of developing countries. Bayer contributes to scaling up contraceptive access and reproductive health programs through this initiative targeting underserved populations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership in Carbon Ventures program for developing cover crops that can be converted into renewable fuel feedstock, supporting sustainable agriculture and carbon reduction goals.

4Global LifeHub Network
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Open innovation network connecting Bayer with academic institutions, research organizations, and technology partners globally to accelerate innovation in life sciences through collaborations and partnerships.

bayer.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Agricultural sustainability initiative connecting Bayer with food chain partners including processors, traders, and retailers to promote sustainable sourcing and regenerative agriculture practices.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Initiative showcasing regenerative agriculture practices on partner farms, demonstrating how advanced technologies can improve sustainability while maintaining agricultural productivity.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature14 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Divergence

Agricultural Biotechnologydivergence.com

Divergence is a St. Louis-based, privately held R&D company founded in 1999 that develops strategies for controlling parasites and other pests, operating in the agricultural biotechnology space.

What Divergence does

Divergence is a privately held research and development company headquartered in St. Louis, Missouri, founded in 1999. According to its firmographic profile, the company is dedicated to the discovery of strategies for the control of parasites and other pests, placing it in the agricultural biotechnology and animal/plant health R&D sector. Its stated product focus is on developing novel parasite and pest control approaches, which historically has spanned agricultural, veterinary, and potentially human health applications.

Between 2001 and 2009, Divergence raised approximately $20.6 million in aggregate across at least six discrete funding events, including venture rounds (with participation from Ag Fund, Cultivian Ventures, Prolog Ventures, and Sandbox Industries) and non-dilutive grant funding from the National Science Foundation. The company's leadership consists of co-founder Angharad Thomas and Vice President of Discovery Research Deryck Jeremy Williams, Ph.D., indicating a research-led operating model centered on scientific discovery rather than commercial sales scale at the time of last disclosed activity.

Material data caveat: The firmographics record lists "10000+" employees, which is fundamentally inconsistent with the disclosed funding scale (~$20M total raised over an eight-year window) and with the operating profile implied by a small St. Louis R&D operation. This figure likely reflects a data-merge artifact and should be treated with caution. No revenue, pricing, customer logos, or post-2009 operating updates are disclosed in the input, so commercial traction cannot be verified.

Divergence firmographics

Firmographics
Name
Divergence
Legal name
Bayer AG
Website
https://divergence.com
Company type
Public
Founded year
1863
Operating status
Operating
Headcount range
11–50 employees
Short description
Divergence is a St. Louis-based, privately held R&D company founded in 1999 that develops strategies for controlling parasites and other pests, operating in the agricultural biotechnology space.
Ownership category
akta.pro rank

Divergence industry classification

Industry
Product category
Agricultural Biotechnology
akta.pro industry
PRIMARYAFABAEAH
Beneficial Insects (Predators & Parasitoids)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)

Keywords

  • Pest control research
  • Parasite control strategies
  • Agricultural biotechnology
  • Crop protection R&D
  • Nematicide discovery

Where Divergence is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Divergence business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations

Revenue model

  1. Pharmaceuticals: Prescription pharmaceuticals across cardiology, oncology, hematology, ophthalmology, chronic kidney disease, and hormonal/reproductive health. Includes both in-market products and pipeline candidates in clinical development.
  2. Crop Science/Agriculture: Agricultural products including crop protection (herbicides, fungicides, insecticides), seeds and traits (including GMO biotechnology and genome editing), agriculture biologicals, and digital farming solutions for farmers worldwide.
  3. Consumer Health/Personal Health: Over-the-counter (OTC) consumer health products including analgesics, allergy relief, digestive health, cough and cold, skin health, hair health, vitamins, and nutritional supplements sold through retail channels.
  4. Radiology/Diagnostic Imaging: Medical imaging equipment and contrast agents for computed tomography (CT), magnetic resonance tomography (MRI), angiography, and PET imaging systems sold to healthcare facilities.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPharmaceutical prescription medications - pricing varies by market and indication

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Divergence product offering

Product offering

Core offering

Divergence is a research and development company focused on discovering new strategies and technologies for the control of parasites and other pests in agricultural settings. The company's work centers on agricultural biotechnology, developing novel approaches to parasitic nematode and crop pest management through targeted R&D programs.

Product overview

Bayer is a global enterprise with core competencies in health care and agriculture. The company operates as a multi-divisional organization with three main pillars: Pharmaceuticals (innovative solutions for preventing, alleviating and treating diseases including cardiology, oncology, hematology, and eye conditions), Consumer Health (personal health products including OTC medicines, vitamins, and health supplements), and Crop Science (agricultural solutions including crop protection chemicals, seeds and traits, digital farming, and biologicals). The Pharmaceuticals division leverages advanced technology platforms including AI, chemoproteomics, PROTACs, RNA-targeting small molecules, and cell and gene therapy. The Agriculture division encompasses regenerative agriculture solutions, digital farming technologies, and biotechnology programs including GMO and genome editing.

Differentiator

Problem solved

Functional benefit

Brands

  • Bayer Crop Science: Agricultural division offering crop protection products, seeds, digital farming solutions, and biotechnology.
  • Bayer Pharmaceuticals
  • Bayer Consumer Health
  • Bayer Environmental Science
  • Bayer Life Sciences

Products and services

  • Parasite and Pest Control R&D Services Research and development services focused on discovering novel strategies and chemistries for the control of parasites (including plant-parasitic nematodes) and other agricultural pests, delivered to agricultural input companies.

Quantifiable outcome

  • Commitment to reducing agriculture's environmental impact through regenerative agriculture and carbon reduction programs
  • +1 more outcomes

Companies that use Divergence

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles1 record

Divergence technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature14 records

Divergence partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Perfuse TherapeuticscoreStrategic or Co-development Partner · 17 June 2026Bayer completed acquisition of Perfuse Therapeutics, a strategic transaction to strengthen Bayer's pharmaceutical pipeline and capabilities in a specific therapeutic area (date: June 2026).
  • The Challenge InitiativecoreStrategic or Co-development PartnerPartnership to improve access to family planning services in urban areas of developing countries. Bayer contributes to scaling up contraceptive access and reproductive health programs through this initiative targeting underserved populations.
  • CoverCressminorStrategic or Co-development PartnerStrategic partnership in Carbon Ventures program for developing cover crops that can be converted into renewable fuel feedstock, supporting sustainable agriculture and carbon reduction goals.
  • Global LifeHub NetworkcoreStrategic or Co-development PartnerOpen innovation network connecting Bayer with academic institutions, research organizations, and technology partners globally to accelerate innovation in life sciences through collaborations and partnerships.
  • Food Chain PartnershipminorStrategic or Co-development PartnerAgricultural sustainability initiative connecting Bayer with food chain partners including processors, traders, and retailers to promote sustainable sourcing and regenerative agriculture practices.
  • Bayer ForwardFarmingminorStrategic or Co-development PartnerInitiative showcasing regenerative agriculture practices on partner farms, demonstrating how advanced technologies can improve sustainability while maintaining agricultural productivity.

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

Divergence competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Divergence financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Divergence leadership team

Management profile

Number of profiles

Profiles2 records

Divergence subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Divergence funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Divergence M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Divergence

What does Divergence do?

Divergence is a research and development company focused on discovering new strategies and technologies for the control of parasites and other pests in agricultural settings. The company's work centers on agricultural biotechnology, developing novel approaches to parasitic nematode and crop pest management through targeted R&D programs.

Is Divergence a public or private company?

Divergence is a public company. It is classified as venture growth investor backed and is currently operating.

When was Divergence founded?

Divergence was founded in 1863. It employs 11 to 50 people.

Where is Divergence based?

Divergence is headquartered in St Louis, United States, in the North America region.

How does Divergence make money?

Four revenue lines are on record. Pharmaceuticals are the primary driver. The others are crop Science/Agriculture, consumer Health/Personal Health and radiology/Diagnostic Imaging.

Does Divergence have an API?

No public API is recorded for Divergence.

What industry is Divergence in?

Divergence's product category is Agricultural Biotechnology. Its primary akta.pro industry code is AFABAEAH, Beneficial Insects (Predators & Parasitoids).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals